New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists
The activation of the human cannabinoid receptor type II (CB2R) is known to mediate analgesic and anti-inflammatory processes without the central adverse effects related to cannabinoid receptor type I (CB1R). In this work we describe the synthesis and evaluation of a novel series of N-aryl-2-pyridon...
Autores principales: | , , , , , , , |
---|---|
Formato: | Artículo (Article) |
Idioma: | Inglés (English) |
Publicado: |
MDPI
2024
|
Materias: | |
Acceso en línea: | https://repositorio.uc.cl/handle/11534/80023 |